Astria Therapeutics, Inc.
Clinical trials sponsored by Astria Therapeutics, Inc., explained in plain language.
-
New hope for HAE patients: long-term navenibart trial expands
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of a drug called navenibart for people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. It is open to adults and teens who were in a previous navenibart study. Participants will receive nav…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New drug STAR-0310 tested in healthy volunteers for first time
Knowledge-focused OngoingThis early-stage trial tests the safety of a new drug called STAR-0310 in 40 healthy adults. Participants receive a single dose of the drug or a placebo, and researchers monitor for side effects. The goal is to gather safety data, not to treat any disease.
Phase: PHASE1 • Sponsor: Astria Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC